Table 5.
Beta 2 HPV E61 | HPV197 CE6 Unique/Total/Coverage | HPV197 NE6 Unique/Total/Coverage |
---|---|---|
TNKS1BP12 | 48/46/36.03 % | 35/42/26.95 % |
TJAP13 | ND | ND |
TANC13 | 1/1/0.54 % | ND |
TANC2 | 27/29/20.50 % | 5/5/4.32 % |
AMBRA1 | 21/23/27.73 % | 5/6/6.70 % |
C21ORF2 | 2/2/9.77 % | 1/1/4.30 % |
MX24 | ND | ND |
NEK13 | 12/12/13.35 % | ND |
UHMK1 | ND | ND |
MTA25 | 2/2/3.89 % | 2/3/5.39 % |
UBR4 | 19/19/6.52 % | 17/19/5.77°% |
KCMF1 | 2/2/13.65 % | ND |
UBA5 | ND | ND |
UFM16 | ND | ND |
JMJD1C3 | 21/27/12.09 % | 9/11/6.38 % |
Data from (White et al., 2012a)
also alpha 9 HPV16, alpha 7 HPV45, and alpha 10 HPV6 E6
HPV17 E6 only
also alpha 4 HPV57, alpha 7 HPV18, alpha 9 HPV52, beta 1 HPV20, and beta 4 HPV92 E6
also alpha 9 HPV16, beta 1 HPV20, HPV26, and beta 4 HPV92 E6
HPV17 E6 only, also alpha 4 HPV57 E6
ND Not Detected